UA90259C2 - CRYSTALLINE FORMS OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIA-ZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), SOLID FORM OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), METHOD FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE AND PARKINSON'S DISEASE - Google Patents

CRYSTALLINE FORMS OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIA-ZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), SOLID FORM OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), METHOD FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE AND PARKINSON'S DISEASE

Info

Publication number
UA90259C2
UA90259C2 UAA200609568A UAA200609568A UA90259C2 UA 90259 C2 UA90259 C2 UA 90259C2 UA A200609568 A UAA200609568 A UA A200609568A UA A200609568 A UAA200609568 A UA A200609568A UA 90259 C2 UA90259 C2 UA 90259C2
Authority
UA
Ukraine
Prior art keywords
methyl
diindolo
ethylthio
pyrrolo
hexahydro
Prior art date
Application number
UAA200609568A
Other languages
English (en)
Russian (ru)
Inventor
Майкл Харольд Рок
Де Диего Хейди Лопес
Ким Лассе Христенсен
Оле Нильсен
Аннерс Буур
Марк Хауэлз
Original Assignee
Х.Луннбек А/С
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Х.Луннбек А/С filed Critical Х.Луннбек А/С
Publication of UA90259C2 publication Critical patent/UA90259C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/23—Heterocyclic radicals containing two or more heterocyclic rings condensed among themselves or condensed with a common carbocyclic ring system, not provided for in groups C07H19/14 - C07H19/22
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
UAA200609568A 2004-02-27 2005-02-24 CRYSTALLINE FORMS OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIA-ZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), SOLID FORM OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), METHOD FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE AND PARKINSON'S DISEASE UA90259C2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DKPA200400326 2004-02-27

Publications (1)

Publication Number Publication Date
UA90259C2 true UA90259C2 (en) 2010-04-26

Family

ID=36607170

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200609568A UA90259C2 (en) 2004-02-27 2005-02-24 CRYSTALLINE FORMS OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIA-ZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), SOLID FORM OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), METHOD FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE AND PARKINSON'S DISEASE

Country Status (10)

Country Link
KR (1) KR20070012644A (ko)
CN (1) CN100591685C (ko)
AR (1) AR047821A1 (ko)
CA (1) CA2762878C (ko)
EA (1) EA200601566A1 (ko)
ES (1) ES2397342T3 (ko)
HK (1) HK1102087A1 (ko)
TW (1) TW200530254A (ko)
UA (1) UA90259C2 (ko)
ZA (1) ZA200606556B (ko)

Also Published As

Publication number Publication date
CN1922196A (zh) 2007-02-28
TW200530254A (en) 2005-09-16
CA2762878C (en) 2014-08-19
HK1102087A1 (en) 2007-11-02
ES2397342T3 (es) 2013-03-06
ZA200606556B (en) 2008-02-27
CA2762878A1 (en) 2005-09-09
EA200601566A1 (ru) 2006-12-29
CN100591685C (zh) 2010-02-24
KR20070012644A (ko) 2007-01-26
AR047821A1 (es) 2006-02-22

Similar Documents

Publication Publication Date Title
HK1122808A1 (en) Preparation and use of tetrahydropyrrolo [3, 2-c]t pyridin-4-one derivatives for treatment of obesitty, psychiatric and neurological disorders
WO2007120752A3 (en) 4, 5-dihydro- [1, 2, 4] triazolo [4, 3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders
WO2006107771A3 (en) PYRAZOLO[3,4-c]QUINOLINES, PYRAZOLO[3,4-c]NAPHTHYRIDINES, ANALOGS THEREOF, AND METHODS
WO2006107853A3 (en) Pyrazolopyridine-1,4-diamines and analogs thereof
WO2006122806A3 (en) 1,3-dihydro-imidazo [4,5-c] quinolin-2-ones as lipid kinase inhibitors
WO2005009370A3 (en) Beta-carboline compounds and analogues thereof and their use as mitogen-activated protein kinase-activated protein kinase-2 inhibitors
EA200800992A1 (ru) 2-амино-7,8-дигидро-6н-пиридо[4,3-d]пиримидин-5-оны, способ их получения, способ терапии с их помощью, компонент композиции и композиция на их основе, 2,4-диоксопиперидиновые соединения для их получения
GB0330043D0 (en) Pyrrolo [2,3-b] pyridine derivatives active as kinase inhibitors process for their preparation and pharmaceutical compositions comprising them
AU2003267203A1 (en) Method for administering thermotherapy to prevent the growth of tumors
WO2009151997A8 (en) Process for producing bicycloaniline derivatives
TW200716589A (en) Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino [4,5-c] pyrrole
IL191160A (en) Use of pyrido [3,2- b] pyrazine-6-yl urine urine for the preparation of drugs to treat diseases caused by the enzyme pi3k inhibition.
IL189276A0 (en) Novel crystalline form of a pyridazino [4,5-b] indole derivative
IL196517A (en) Use of (12r, 10s, 9s) –– 10– Hydroxy – 10 – Hydroxymethyl –– 9 – Methyl – 12,11,10,9,3,2 – Hexahydro-12,9-Epoxy-H1-Diindolo [1 , 2,3 – fg: 3 ′, 2 ′, 1′ – kl] pyrrolo [3,4– i] –6,1– benzodiazomine-1-one for the preparation of a drug for the treatment of myelo-proliferative diseases associated with jak2 activation
PT1730144E (pt) Compostos de 1,4,8-triaza-espiro[4.5]decan-2-ona substituídos
SI1685125T1 (sl) Derivati pirola, primerni za zdravljenje proliferativnih bolezni
WO2006027370A8 (en) PREPARATION OF 9-HYDROXY-3- (2-HYDROXYETHYL) -2-METHYL-4H-PYRID0[1, 2-a] PYRIMIDIN-4-ONE AND CRYSTALS THEREOF
WO2008100448A3 (en) Method of treating cell proliferative disorders using growth hormone secretagogues
ZA200809016B (en) 4, 5-Dihydro-[1,2,4] Triazolo [4,3-F] PteridinesS as protein kinase PLK1 inhibitors for the treatment of proliferative disorders
UA90259C2 (en) CRYSTALLINE FORMS OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIA-ZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), SOLID FORM OF [9S-(9,10,12)]-5,16-BIS[(ETHYLTHIO)METHYL]-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-9,12-EPOXY-1H-DIINDOLO[1,2,3-fg:3',2',1'-kl]PYRROLO[3,4-i][1,6]BENZODIAZOCINE-10-CARBOXYLIC ACID METHYL ESTER (VARIANTS), METHOD FOR THE TREATMENT OF NEURODEGENERATIVE DISEASE AND PARKINSON'S DISEASE
IL187441A0 (en) Derivatives of 6,7-dihydro-5h-imidazo[1,2-a] imidazole-3-sulfonic acid
AU2003256006A1 (en) Improved process for preparation of risperidone
IL176471A0 (en) Process for the preparation of triazolopyrimidines
ZA200605930B (en) Crystalline forms of 5,11-dihydro-11-ethyl-5-methyl-8-{2-{(1-oxido-4-quinolinyl)oxyl}ethyl}-6H-dipyrido[3,2-B:2',3'-e][1,4]diazepin-6-one
NO20064348L (no) Krystallinske former av en farmasoytisk forbindelse